Abeona Therapeutics (ABEO)
(Delayed Data from NSDQ)
$4.98 USD
-0.12 (-2.35%)
Updated Jul 29, 2024 04:00 PM ET
After-Market: $4.98 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | -0.33 |
EPS Last Quarter | -0.53 |
Last EPS Surprise | -12.77% |
ABR | 1.00 |
Earnings ESP
|
-35.34% |
---|---|
Current Year | -1.81 |
Next Year | -1.26 |
EPS (TTM) | -2.09 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | 15.83M |
# of Estimates | NA | NA | NA | 4 |
High Estimate | NA | NA | NA | 24.60M |
Low Estimate | NA | NA | NA | 10.00M |
Year ago Sales | 3.50M | 0.00M | 3.50M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.33 | -0.33 | -1.81 | -1.26 |
# of Estimates | 4 | 4 | 5 | 4 |
Most Recent Consensus | -0.45 | -0.36 | -2.05 | -1.18 |
High Estimate | -0.26 | -0.28 | -1.36 | -1.11 |
Low Estimate | -0.45 | -0.36 | -2.07 | -1.50 |
Year ago EPS | -0.44 | -0.48 | -2.05 | -1.81 |
Year over Year Growth Est. | 25.00% | 31.25% | 11.71% | 30.52% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 0 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.33 | -0.33 | -1.81 | -1.26 |
7 Days Ago | -0.33 | -0.33 | -1.81 | -1.26 |
30 Days Ago | -0.29 | -0.31 | -1.75 | -1.28 |
60 Days Ago | -0.38 | -0.42 | -1.78 | -1.44 |
90 Days Ago | -0.50 | -0.54 | -2.14 | -1.94 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.45 | -0.36 | -2.05 | -1.18 |
Zacks Consensus Estimate | -0.33 | -0.33 | -1.81 | -1.26 |
Earnings ESP | -35.34% | -10.77% | -13.26% | 6.16% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.53 | -0.64 | -0.48 | -0.44 | NA |
Estimate | -0.47 | -0.51 | -0.53 | -0.66 | NA |
Difference | -0.06 | -0.13 | 0.05 | 0.22 | 0.02 |
Surprise | -12.77% | -25.49% | 9.43% | 33.33% | 1.13% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more